MAP1LC3B and breast cancer: This study revealed an increase in the LC3B I more than LC3B II isoform in breast cancer cells upon proteasome inhibition (Fig. 2), which suggests that these cells are likely to initiate autophagy, yet unable to finish the conversion process.